PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Zeyu Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Endoscopy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Cisplatin, Protein-Arginine Deiminase Type 4, Esophageal Squamous Cell Carcinoma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Pudong Health Committee of Shanghai, Outstanding Young Medical Talents and Outstanding Projects of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Background
Oesophageal squamous cell carcinoma (OSCC) is a highly lethal cancer characterized by its aggressive nature and chemotherapy resistance. Peptidylarginine deiminase 4 (PADI4) regulates protein citrullination and is associated with various cancer developments. The role of PADI4 in OSCC progression and chemoresistance remains unexplored.
Methods
The protein interactions were conducted by immunoprecipitation assays. Quantitative real‐time PCR and western blotting were utilized to quantifyexpression levels in cancer cells. The stem‐like properties were assessed through spheroid growth assays and Cancer Stem Cells (CSCs) markers. Additionally, the resistance of cancer cells to cisplatin was evaluated using CCK8 assay.
Results
This study shows that PADI4 promotes cellular stemness, contributing to the progression and chemoresistance of OSCC. Mechanistically, PADI4 facilitates the citrullination of protein arginine methyltransferase 2 (PRMT2), a process essential for the stabilization of PRMT2 expression and the enhancement of its function in promoting the transcription of IDs family (ID1 and ID2) via histone arginine methylation. This mechanism subsequently increases tumour stemness and contributes to the cisplatin resistance observed in OSCC. Mutations at the R312 site or inhibition by GSK484 can attenuate tumour stemness in OSCC, thereby reducing cisplatin resistance.
Conclusion
PADI4 promotes citrullination and stabilization of PRMT2, enhancing its function in upregulating ID1 and ID2 expression via histone arginine methylation, which increases stemness and contributes to cisplatin resistance in OSCC; this effect can be mitigated by R312 mutations or GSK484 inhibition, reducing stemness and cisplatin resistance. Key points The role of citrullinization in cisplatin resistance of OSCC. PADI4 citrullinate of PRMT2 and stabilize PRMT2. PADI4 citrullinate of PRMT2 promoting the transcription of IDs family (ID1, ID2 and ID3) via histone arginine methylation. PADI4 citrullinated PRMT2 affected the combination of PRMT2 and USP7. PADI4 citrullinate of PRMT2 at R312 site. PADI4 inhibitor GSK484 can affect the stemness of OSCC and cisplatin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Endoscopy Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Zeyu Wang, Meidong Xu
Förderung
- National Natural Science Foundation of China
- Pudong Health Committee of Shanghai
- Outstanding Young Medical Talents and Outstanding Projects of Shanghai Municipal Health Commission
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wang, Z., Wu, H., Li, Z., Chen, Z., Feng, A., Chu, Y., Fang, K., Zhang, Z., Zhao, Z., Leng, Z., Zhang, S., Wang, X., He, L., Chen, T., & Xu, M. (2025). PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70272
Vancouver
Wang Z, Wu H, Li Z, Chen Z, Feng A, Chu Y, et al. PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70272
BibTeX
@article{Wang2025,
author = {Wang, Zeyu and Wu, Hao and Li, Zhaoxing and Chen, Zhukai and Feng, Anqi and Chu, Yuan and Fang, Kang and Zhang, Zehua and Zhao, Ziying and Leng, Zhuyun and Zhang, Shihan and Wang, Xiaoyuan and He, Lingnan and Chen, Tao and Xu, Meidong},
title = {PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70272}
}
EUVIMED